New Drug Trials

UT-15 is an experimental stable form of prostacylin that can be delivered non-intravenously. Prostacylin helps dilate pulmonary capillaries and appears to help protect the pulmonary endothelial cells from erosion. To be assessed for whether it is appropriate for you to participate in a UT-15 clinical trial, contact one of the Clinical Investigators listed below.